OVA G4 peptide is a variant of the agonist ovalbumin peptide SIINFEKL (OVA) (257-264). SIINFEKL is routinely used to stimulate ovalbumin-specific T cells and to test new vaccine adjuvants can form a stable hydrogel.
OVA G4 peptide is a synthetic peptide derived from the ovalbumin (OVA) protein sequence, specifically encompassing the immunodominant epitope recognized by major histocompatibility complex (MHC) molecules. As a well-characterized peptide fragment, it plays a pivotal role in immunological research, particularly in studies focused on antigen processing, T-cell receptor specificity, and peptide-MHC interactions. Its defined amino acid sequence and reproducible biochemical properties make it a preferred tool for probing cellular immune responses, validating immunoassays, and modeling antigen presentation mechanisms in vitro and in vivo.
Antigen Presentation Studies: OVA G4 peptide serves as an essential reagent for dissecting the molecular mechanisms of antigen processing and presentation. Researchers utilize it to load antigen-presenting cells (APCs) in order to study the efficiency and specificity of peptide-MHC complex formation. By providing a defined epitope, the peptide facilitates controlled investigations into how APCs process exogenous proteins and present peptide fragments to T lymphocytes, enabling detailed mapping of immune recognition pathways.
T-cell Activation Assays: As a recognized epitope for both CD4+ and CD8+ T cells in various model systems, the peptide is widely used to stimulate antigen-specific T-cell populations in vitro. This application is critical for evaluating T-cell proliferation, cytokine secretion profiles, and cytotoxic responses. The precise sequence of the peptide allows for reproducible activation of OVA-specific T-cell clones, supporting studies in immunogenicity, tolerance mechanisms, and vaccine development.
Immunological Model Systems: The OVA G4 peptide is a cornerstone in the development and refinement of transgenic mouse models expressing T-cell receptors specific for ovalbumin-derived epitopes. These models are instrumental in elucidating the dynamics of T-cell selection, differentiation, and memory formation. By providing a standardized peptide antigen, it enables consistent experimental conditions for comparative immunological studies and the validation of novel immunotherapeutic approaches.
Peptide-MHC Binding Analysis: The defined sequence and binding affinity of the peptide to specific MHC molecules make it an ideal candidate for quantitative and qualitative studies of peptide-MHC interactions. Researchers employ it in binding assays, structural analyses, and computational modeling to understand the molecular determinants of epitope recognition. Such studies are fundamental for advancing knowledge in antigen design, immune repertoire analysis, and the development of MHC tetramers for flow cytometry applications.
Immunoassay Development: The OVA G4 peptide is frequently incorporated as a positive control or reference standard in various immunoassays, including ELISPOT, ELISA, and intracellular cytokine staining protocols. Its predictable immunogenicity and compatibility with a range of assay formats support the calibration and validation of immune monitoring tools. By providing a reliable benchmark, the peptide enhances the accuracy and reproducibility of experimental results in both basic and applied immunology research.
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More